Are SPARC latest results good or bad?
SPARC's latest results show a decline in net sales to Rs 9.64 crore, the lowest in five quarters, alongside increased interest expenses. However, it achieved its highest operating profit and profit after tax in the same period, indicating mixed performance overall.
Sun Pharma Advanced Research Company (SPARC) has reported its financial results for the quarter ending June 2025, which reveal a complex operational landscape. The company experienced a notable decline in net sales, which fell to Rs 9.64 crore, marking a significant reduction compared to the previous quarter and representing the lowest sales figure in the last five quarters. This decline in sales is coupled with a rise in interest expenses, which increased to Rs 6.19 crore, indicating higher borrowing costs.On a more positive note, SPARC achieved its highest operating profit (PBDIT) in the last five quarters at Rs -52.08 crore, and the profit after tax (PAT) also reached its highest level in the same period at Rs -51.87 crore. Additionally, earnings per share (EPS) improved to Rs -1.60, suggesting a shift towards greater profitability for shareholders.
The company also recorded its highest non-operating income in five quarters at Rs 9.14 crore, although the sustainability of this income remains uncertain. Overall, SPARC has seen an adjustment in its evaluation, reflecting the mixed results of the quarter.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
